Village Farms International (VFF) 10-Q 8 Nov 23 2023 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2023	Nov. 08, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Trading Symbol	VFF
Entity Registrant Name	VILLAGE FARMS INTERNATIONAL, INC.
Entity Central Index Key	0001584549
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Shell Company	false
Entity Small Business	true
Entity Emerging Growth Company	false
Security Exchange Name	NASDAQ
Entity Address, Country	CA
Title of 12(b) Security	Common Shares, without par value
Entity File Number	001-38783
Entity Incorporation State Country Code	A6
Entity Tax Identification Number	98-1007671
Entity Address, State or Province	BC
Entity Address, Address Line One	4700-80th Street
Entity Address, City or Town	Delta
Entity Address, Postal Zip Code	V4K 3N3
City Area Code	604
Local Phone Number	940-6012
Document Quarterly Report	true
Document Transition Report	false
Entity Common Stock, Shares Outstanding		110,238,929

Condensed Consolidated Statemen

Condensed Consolidated Statements of Financial Position - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 35,483	$ 16,676
Restricted cash	5,000	5,000
Trade receivables	28,541	27,558
Inventories	77,059	70,582
Other receivables	332	309
Income tax receivable, net	2	6,900
Prepaid expenses and deposits	6,747	5,959
Total current assets	153,164	132,984
Non-current assets
Property, plant and equipment	202,198	207,701
Investments	2,109	2,109
Goodwill	66,118	66,225
Intangibles	34,955	37,157
Deferred tax asset	4,201	4,201
Right-of-use assets	13,069	9,132
Other assets	1,888	5,776
Total assets	477,702	465,285
Current liabilities
Line of credit	4,000	7,529
Trade payables	19,378	24,894
Current maturities of long-term debt	9,284	9,646
Accrued sales taxes	14,029	11,594
Accrued loyalty program	1,817	2,060
Accrued liabilities	15,895	13,064
Lease liabilities - current	1,955	1,970
Other current liabilities	2,529	1,458
Total current liabilities	68,887	72,215
Non-current liabilities
Long-term debt	39,811	43,821
Deferred tax liability	18,992	19,756
Lease liabilities - non-current	11,804	7,785
Other liabilities	1,869	1,714
Total liabilities	141,363	145,291
Commitments and contingencies
MEZZANINE EQUITY
Redeemable non-controlling interest	15,238	16,164
SHAREHOLDERS’ EQUITY
Common stock, no par value per share - unlimited shares authorized;110,238,929 shares issued and outstanding at September 30, 2023 and 91,788,929 shares issued and outstanding at December 31, 2022.	386,719	372,429
Additional paid in capital	25,635	13,372
Accumulated other comprehensive loss	(8,187)	(8,371)
Retained earnings	(83,682)	(74,367)
Total Village Farms International, Inc. shareholders' equity	320,485	303,063
Non-controlling interest	616	767
Total shareholders' equity	321,101	303,830
Total liabilities, mezzanine equity and shareholders’ equity	$ 477,702	$ 465,285

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Financial Position (Parenthetical) - $ / shares	Sep. 30, 2023	Dec. 31, 2022
Assets [Abstract]
Common stock, no par value	$ 0	$ 0
Common Stock, Shares, Issued	110,238,929	91,788,929
Common Stock, Shares, Outstanding	110,238,929	91,788,929

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Income (Loss) and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Sales	$ 69,510	$ 71,056	$ 211,378	$ 224,115
Cost of sales	(54,889)	(62,682)	(172,958)	(199,514)
Gross margin	14,621	8,374	38,420	24,601
Selling, general and administrative expenses	(15,822)	(17,794)	(49,980)	(54,245)
Interest expense	(988)	(982)	(3,532)	(2,330)
Interest income	262	60	741	129
Foreign exchange loss, net	(971)	(1,963)	(302)	(2,171)
Other (expense) income	(19)	(10)	5,613	(7)
Write-off of joint venture loan				(592)
Impairments				(29,799)
Loss before taxes and loss from equity method investments	(2,917)	(12,315)	(9,040)	(64,414)
Recovery of (provision for) income taxes	1,664	3,183	(269)	14,563
Loss from equity method investments				(2,667)
Loss including non-controlling interests	(1,253)	(9,132)	(9,309)	(52,518)
Less: net (income) loss attributable to non-controlling interests, net of tax	(46)	387	(6)	701
Net loss attributable to Village Farms International, Inc. shareholders	$ (1,299)	$ (8,745)	$ (9,315)	$ (51,817)
Basic loss per share attributable to Village Farms International, Inc. shareholders	$ (0.01)	$ (0.1)	$ (0.09)	$ (0.59)
Diluted loss per share attributable to Village Farms International, Inc. shareholders	$ (0.01)	$ (0.1)	$ (0.09)	$ (0.59)
Weighted average number of common shares used in the computation of net loss per share (in thousands):
Basic	110,239	88,684	108,214	88,543
Diluted	110,239	88,684	108,214	88,543
Loss including non-controlling interests	$ (1,253)	$ (9,132)	$ (9,309)	$ (52,518)
Other comprehensive income (loss):
Foreign currency translation adjustment	(5,986)	(14,780)	(899)	(17,911)
Comprehensive loss including non-controlling interests	(7,239)	(23,912)	(10,208)	(70,429)
Comprehensive (income) loss attributable to non-controlling interests	353	1,499	(50)	1,929
Comprehensive loss attributable to Village Farms International, Inc. shareholders	$ (6,886)	$ (22,413)	$ (10,258)	$ (68,500)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Changes in Shareholders' Equity and Mezzanine Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive (Loss) Income [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]
Beginning Balance at Dec. 31, 2021	$ 408,405	$ 365,561	$ 9,369	$ 6,696	$ 26,779
Beggining Balance (in shares) at Dec. 31, 2021		88,234
Mezzanine Equity, Beginning balance at Dec. 31, 2021	16,433
Proceeds from issuance of common stock / Shares issued in public offering, net of issuance costs	824	$ 824
Proceeds from issuance of common stock / Shares issued in pubic offering, net of issuance costs (in shares)		450
Shares issued on exercise of stock options	192	$ 176	16
Shares issued on exercise of stock options (in shares)		345
Share-based compensation	3,004		3,004
Recognition of non-controlling interest on acquisition	767					$ 767
Cumulative translation adjustment	(17,911)			(17,911)
Net (loss) Income	(51,817)				(51,817)
Mezzanine Equity, Net loss	(701)
Ending Balance at Sep. 30, 2022	343,464	$ 366,561	12,389	(11,215)	(25,038)	767
Ending Balance (in shares) at Sep. 30, 2022		89,029
Mezzanine Equity, Ending balance at Sep. 30, 2022	15,732
Beginning Balance at Jun. 30, 2022	364,472	$ 365,737	11,463	3,565	(16,293)
Beggining Balance (in shares) at Jun. 30, 2022		88,572
Mezzanine Equity, Beginning balance at Jun. 30, 2022	16,119
Proceeds from issuance of common stock / Shares issued in public offering, net of issuance costs	824	$ 824
Proceeds from issuance of common stock / Shares issued in pubic offering, net of issuance costs (in shares)		450
Share-based compensation (in shares)		7
Share-based compensation	926		926
Recognition of non-controlling interest on acquisition	767					767
Cumulative translation adjustment	(14,780)			(14,780)
Net (loss) Income	(8,745)				(8,745)
Mezzanine Equity, Net loss	(387)
Ending Balance at Sep. 30, 2022	343,464	$ 366,561	12,389	(11,215)	(25,038)	767
Ending Balance (in shares) at Sep. 30, 2022		89,029
Mezzanine Equity, Ending balance at Sep. 30, 2022	15,732
Beginning Balance at Dec. 31, 2022	303,830	$ 372,429	13,372	(8,371)	(74,367)	767
Beggining Balance (in shares) at Dec. 31, 2022		91,789
Mezzanine Equity, Beginning balance at Dec. 31, 2022	16,164
Proceeds from issuance of common stock / Shares issued in public offering, net of issuance costs	14,207	$ 14,207
Proceeds from issuance of common stock / Shares issued in pubic offering, net of issuance costs (in shares)		18,350
Warrants issued in public offering	9,128		9,128
Shares issued on exercise of stock options	83	$ 83
Shares issued on exercise of stock options (in shares)		100
Share-based compensation	3,135		3,135
Cumulative translation adjustment	213			184		29
Net (loss) Income	(9,495)				(9,315)	(180)
Mezanine Equity, Cumulative translation adjustment	(1,111)
Mezzanine Equity, Net loss	185
Ending Balance at Sep. 30, 2023	321,101	$ 386,719	25,635	(8,187)	(83,682)	616
Ending Balance (in shares) at Sep. 30, 2023		110,239
Mezzanine Equity, Ending balance at Sep. 30, 2023	15,238
Beginning Balance at Jun. 30, 2023	326,608	$ 386,719	24,888	(3,284)	(82,383)	668
Beggining Balance (in shares) at Jun. 30, 2023		110,239
Mezzanine Equity, Beginning balance at Jun. 30, 2023	16,223
Share-based compensation	747		747
Cumulative translation adjustment	(4,874)			(4,903)		29
Net (loss) Income	(1,380)				(1,299)	(81)
Mezanine Equity, Cumulative translation adjustment	(1,111)
Mezzanine Equity, Net loss	126
Ending Balance at Sep. 30, 2023	321,101	$ 386,719	$ 25,635	$ (8,187)	$ (83,682)	$ 616
Ending Balance (in shares) at Sep. 30, 2023		110,239
Mezzanine Equity, Ending balance at Sep. 30, 2023	$ 15,238

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows provided by (used in) operating activities:
Net loss attributable to Village Farms International, Inc. shareholders	$ (9,315)	$ (51,817)
Adjustments to reconcile net loss attributable to Village Farms International, Inc. shareholders to net cash provided by (used in) operating activities:
Depreciation and amortization	11,726	11,061
Amortization of deferred charges	102	171
Share of loss from joint ventures		2,667
Net loss attributable to non-controlling interest	6	(701)
Interest expense	3,532	2,330
Interest income	(741)	(129)
Interest paid on long-term debt	(3,645)	(2,989)
Unrealized foreign exchange loss	92	77
Impairments		29,799
Write-off of joint venture loan		592
Loss (gain) on disposal of assets	1	(7)
Non-cash lease expense	1,615	775
Share-based compensation	3,135	3,004
Deferred income taxes	1,748	(19,670)
Changes in non-cash working capital items	(1,451)	11,621
Net cash provided by (used in) operating activities	6,805	(13,216)
Cash flows (used in) provided by investing activities:
Purchases of property, plant and equipment	(4,358)	(12,869)
Acquisitions, net		(4,693)
Issuance of note receivable		(1,914)
Repayment of note receivable	835
Net cash used in investing activities	(3,523)	(19,476)
Cash flows provided by (used in) financing activities:
Proceeds from borrowings		4,000
Repayments on borrowings	(7,858)	(6,262)
Proceeds from issuance of common stock and warrants	24,772	824
Issuance costs	(1,437)
Proceeds from exercise of stock options	83	192
Payments on capital lease obligations		(782)
Net cash provided by (used in) financing activities	15,560	(2,028)
Effect of exchange rate changes on cash and cash equivalents	(35)	(782)
Net increase (decrease) in cash, cash equivalents and restricted cash	18,807	(35,502)
Cash, cash equivalents and restricted cash, beginning of period	21,676	58,667
Cash, cash equivalents and restricted cash, end of period	40,483	$ 23,165
Non-cash investing and financing activities:
Operating lease right-of-use assets	5,578
Operating lease liabilities	$ 5,578

Business, Basis Of Presentation

Business, Basis Of Presentation And Significant Accounting Policies	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Business, Basis Of Presentation And Significant Accounting Policies	1. BUSINESS, BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES Nature of Business Village Farms International, Inc. (“VFF” and, together with its subsidiaries, the “Company”, “we”, “us”, or “our”) is a corporation existing under the Ontario Business Corporations Act. VFF’s principal operating subsidiaries as of September 30, 2023 are Village Farms Canada Limited Partnership, Village Farms, L.P., Pure Sunfarms Corp. (“Pure Sunfarms”), and Balanced Health Botanicals, LLC (“Balanced Health”). VFF also owns a 70 % interest in Rose LifeScience Inc. (“Rose”) and an 85 % interest in Leli Holland B.V. ("Leli"). The address of the registered office of VFF is 4700-80th Street, Delta, British Columbia, Canada, V4K 3N3. The Company’s shares are listed on Nasdaq Capital Market (“Nasdaq”) under the symbol “VFF”. Village Farms owns and operates sophisticated, highly intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells premium-quality tomatoes, bell peppers, and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. Through its 70 % ownership of Rose, the Company has a substantial presence in the Province of Quebec as a cannabis supplier, producer and commercialization expert. The Company’s wholly owned subsidiary, Balanced Health, develops and sells high-quality cannabidiol (“CBD”) based products including ingestible, edible and topical applications. Basis of Presentation The accompanying condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and with the instructions for Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and footnote disclosures normally included in the annual audited consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. The accompanying condensed consolidated statement of financial position as of December 31, 2022 is derived from the Company’s audited financial statements as of that date. Because certain information and footnote disclosures have been condensed or omitted, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto as of and for the year ended December 31, 2022 contained in the Company’s 2022 Annual Report on Form 10-K. In management’s opinion, all normal and recurring adjustments considered necessary for a fair presentation of the financial position, results of operations, and cash flows for the periods presented have been included. When necessary, certain prior year amounts have been reclassified to conform with the current period presentation. For the three and nine months ended September 30, 2022 , share-based compensation has been reclassified to selling, general and administrative expenses on the condensed consolidated Statements of Operations and Comprehensive Income (Loss) to conform with the current period presentation. Interim period operating results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year. The Company believes that the disclosures made in these consolidated financial statements are adequate to make the information not misleading. Principals of Consolidation The accompanying condensed consolidated financial statements include Village Farms International, Inc. and its subsidiaries and include the accounts of all majority-owned subsidiaries over which the Company exercises control and, when applicable, entities in which the Company has a controlling financial interest. All significant intercompany balances and transactions have been eliminated in consolidation. Other parties’ interests in entities that the Company consolidates are reported as non-controlling interests within equity, except for mandatorily redeemable non-controlling interests, which are recorded within mezzanine equity. Net income or loss attributable to non-controlling interests is reported as a separate line item below net income or loss. The Company applies the equity method of accounting for its investments in entities for which it does not have a controlling financial interest, but over which it has the ability to exert significant influence. For equity investees in which the Company has an undivided interest in the assets, liabilities and profits or losses of an unconsolidated entity, but does not exercise control over the entity, the Company consolidates its proportional interest in the accounts of the entity. Translations of Foreign Currencies The assets and liabilities of foreign subsidiaries with a functional currency other than the U.S. dollar are translated into U.S. dollars at period-end exchange rates, with resulting translation gains or losses included within other comprehensive income or loss. Revenue and expenses are translated into U.S. dollars at average rates of exchange during the applicable period. Substantially all the Company’s foreign operations use their local currency as their functional currency. For foreign operations for which the local currency is not the functional currency, the operation’s non-monetary assets are remeasured into U.S. dollars at historical exchange rates. All other accounts are remeasured at current exchange rates. General Economic, Regulatory and Market Conditions The Company has experienced, and may continue to experience, direct and indirect negative effects on its business and operations from negative economic, regulatory and market conditions, including recent inflationary effects on fuel prices, labor and materials costs, rising interest rates, potential recessionary impacts and supply chain disruptions that could negatively affect demand for new projects and/or delay existing project timing or cause increased project costs. The extent to which general economic, regulatory and market conditions could affect the Company’s business, operations and financial results is uncertain as it will depend upon numerous evolving factors that management may not be able to accurately predict, and, therefore, any future impacts on the Company’s business, financial condition and/or results of operations cannot be quantified or predicted with specificity. Recent Accounting Pronouncements No accounting pronouncements recently issued or newly effective have had, or are expected to have, a material impact on the Company’s condensed consolidated financial statements.

Inventories

Inventories	9 Months Ended
	Sep. 30, 2023
Inventory Disclosure [Abstract]
Inventories	2. INVENTORIES Inventories consisted of the following as of: Classification September 30, 2023 December 31, 2022 Cannabis: Raw materials $ 1,180 $ 1,089 Work-in-progress 6,452 10,872 Finished goods 47,510 36,094 Packaging 7,149 6,909 Produce and Energy: Crop inventory 14,028 14,886 Purchased produce inventory 683 599 Spare parts inventory and packaging 57 133 Inventory $ 77,059 $ 70,582

Property Plant And Equipment

Property Plant And Equipment	9 Months Ended
	Sep. 30, 2023
Property, Plant and Equipment [Abstract]
Property Plant And Equipment	3. PROPERTY, PLANT AND EQUIPMENT Property, plant and equipment consisted of the following as of: Classification September 30, 2023 December 31, 2022 Land $ 13,387 $ 13,411 Leasehold and land improvements 5,533 5,372 Buildings 214,014 214,146 Machinery and equipment 85,494 82,396 Construction in progress 11,786 10,033 Less: Accumulated depreciation ( 128,016 ) ( 117,657 ) Property, plant and equipment, net $ 202,198 $ 207,701

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	4. GOODWILL AND INTANGIBLE ASSETS Goodwill The following table presents the changes in the carrying value of goodwill by reportable segment for the nine months ended September 30, 2023: Cannabis - Canada Cannabis - United States Total Balance as of December 31, 2022 $ 44,886 $ 21,339 $ 66,225 Foreign currency translation adjustment ( 107 ) — ( 107 ) Balance as of September 30, 2023 $ 44,779 $ 21,339 $ 66,118 Intangible Assets Intangibles consisted of the following as of: Classification September 30, 2023 December 31, 2022 Licenses $ 17,983 $ 17,691 Brand and trademarks* 12,710 12,719 Customer relationships 13,260 13,291 Computer software 1,952 1,955 Other* 144 144 Less: Accumulated amortization ( 6,464 ) ( 4,013 ) Less: Impairments ( 4,630 ) ( 4,630 ) Intangibles, net $ 34,955 $ 37,157 * Indefinite-lived intangible assets The expected future amortization expense for definite-lived intangible assets as of September 30, 2023 was as follows: Fiscal period Remainder of 2023 $ 777 2024 3,107 2025 3,021 2026 2,932 2027 2,932 Thereafter 13,962 Intangibles, net $ 26,731 Assessment for Indicators of Impairment At the end of each reporting period, the Company assesses whether events or changes in circumstances have occurred that would indicate an impairment. The Company considers external and internal factors, including overall financial performance and relevant entity-specific factors, as part of this assessment. During the first nine months of 2023, the Company considered qualitative factors in assessing for impairment indicators for the Company’s U.S. and Canadian cannabis segments. As part of this assessment, the Company considered both external and internal factors, including overall financial performance and outlook. At September 30, 2023, the Company concluded that no impairment indicators existed as no events or circumstances occurred that would, more likely than not, reduce the fair value of the reporting units to be below their carrying amounts. Throughout 2022, the Company recognized macroeconomic challenges, decreases in market capitalization, decreases in transaction multiples, and continued ambiguity in federal regulations with respect to the U.S. CBD market. During the second quarter of 2022, when the Company considered these qualitative factors in assessing impairment indicators it concluded that the Company's U.S. - Cannabis segment more likely than not was impaired. The Company tested that segment’s assets, including goodwill and intangible assets for impairment. Cannabis - U.S. - Goodwill The recoverable amount of the reporting unit was determined based on a transaction multiple of somewhat similar CBD-based companies. Management concluded that as of June 30, 2022, the recoverable amount was lower than its carrying amount and as a result, an impairment charge to goodwill of $ 25,169 was allocated to the reporting unit. The significant assumptions applied to the determination of the recoverable amount are described below: • Transaction multiples: A market-based revenue multiple of 1.6 x was utilized to determine the recoverable amount. A decrease in the multiple of .25 x, would increase the impairment to goodwill by $ 7,000 . Cannabis - U.S. - Brand The recoverable amount of the brand was determined based on a discounted cash flow projection. Specifically, the Company utilized a relief from royalty valuation technique to arrive at the recoverable amount of the brand. Management concluded that as of June 30, 2022, the recoverable amount was lower than its carrying value of $ 9,250 and as a result, an impairment charge to the brand intangible of $ 4,630 was allocated to the reporting unit. The significant assumptions applied to the determination of the recoverable amount are described below: • Post-tax discount rate: A market participant post-tax discount rate applied to the after-tax forecast cash flows was 11 %. An increase of 1 % to the discount rate would increase the impairment by approximately $ 530 . • Royalty rate: An incremental royalty rate of 4.0 % of revenues was applied to brand-specific revenues. A decrease to the incremental royalty rate by 0.5 % would increase the impairment to brand by $ 1,490 . • Future revenues: A decrease in future revenues by 10 % would increase the impairment by approximately $ 470 .

Line of Credit and Long-term De

Line of Credit and Long-term Debt	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Line of Credit and Long-term Debt	5. LINE OF CREDIT AND LONG-TERM DEBT The following table provides details for the carrying values of debt as of: September 30, 2023 December 31, 2022 Term Loan - ("FCC Loan") - repayable by monthly principal payments of $ 164 and accrued interest at a rate of 8.93 %; matures April 1, 2025 $ 23,280 $ 24,755 Term Loan - Pure Sunfarms - C$ 19.0 M - Canadian prime interest rate plus an applicable margin, repayable in quarterly payments equal to 2.50 % of the outstanding principal amount, interest rate of 9.20 %; matures February, 2026 8,534 9,664 Term loan - Pure Sunfarms - C$ 25.0 M - Canadian prime interest rate plus an applicable margin, repayable in quarterly payments equal to 2.50 % of the outstanding principal amount starting June 30, 2021 , interest rate of 9.20 %; matures February, 2026 13,449 14,867 BDC Facility - Pure Sunfarms - non-revolving demand loan repayable by monthly principal payments of C$ 52 and accrued interest at a rate of 10.95 %, matures December 31, 2031 3,832 4,181 Total $ 49,095 $ 53,467 On March 13, 2023, the Company entered into a Note Modification Agreement (the “Modification”) for its line of credit ("Operating Loan"). The Modification eliminated the use of LIBOR as a basis to determine certain interest rates and transitioned to the Secured Overnight Financing Rate (“SOFR”) for such purposes. This Modification did not have a material effect on the Company's results of operations or its financial position. The Company’s Operating Loan had $ 4,000 amount drawn on the facility as of September 30, 2023 and December 31, 2022. The carrying value of the assets and securities pledged as collateral for the FCC Loan as of September 30, 2023 and December 31, 2022 was $ 122,823 and $ 113,159 , respectively. The carrying value of the assets pledged as collateral for the Operating Loan as of September 30, 2023 and December 31, 2022 was $ 25,553 and $ 26,666 , respectively. The Pure Sunfarms line of credit had $ 0 and $ 3,529 outstanding as of September 30, 2023 and December 31, 2022 , respectively. Pure Sunfarms had an outstanding letter of credit issued to BC Hydro against the revolving line of credit of C$ 0 and C$ 4,145 as of September 30, 2023 and December 31, 2022, respectively. The Company is required to comply with financial covenants, measured either quarterly or annually depending on the covenant. The Company was in compliance with all its credit facility covenants as of September 30, 2023. The weighted average annual interest rate on short-term borrowings as of September 30, 2023 and December 31, 2022 was 9.86 % and 9.12 %, respectively. Accrued interest payable on all long-term debt as of September 30, 2023 and December 31, 2022 was $ 385 and $ 398 , respectively, and these amounts are included in accrued liabilities in the Condensed Consolidated Statements of Financial Position. The aggregate annual principal maturities of long-term debt for the remainder of 2023 and thereafter are as follows: Remainder of 2023 $ 1,660 2024 5,814 2025 24,668 2026 14,652 2027 460 Thereafter 1,841 Total $ 49,095

Financial Instruments

Financial Instruments	9 Months Ended
	Sep. 30, 2023
Investments, All Other Investments [Abstract]
Financial Instruments	6. FINANCIAL INSTRUMENTS The Company’s financial instruments include cash and cash equivalents, trade receivables, note receivables, investments, trade payables, accrued liabilities, lease liabilities, note payables and debt. The carrying value of cash and cash equivalents, trade receivables, notes receivable, trade payables, and accrued liabilities approximate their fair values due to the short-term maturity of these financial instruments. The carrying value of lease liabilities, notes payable, and debt approximate their fair values due to insignificant changes in credit risk. For its investments, the Company has selected the practicability election to fair value measurement, under which the investment is measured at cost, less impairment, plus or minus observable price changes of an identical or similar investment.

Related Party Transactions And

Related Party Transactions And Balances	9 Months Ended
	Sep. 30, 2023
Related Party Transactions [Abstract]
Related Party Transaction And Balances	7. RELATED PARTY TRANSACTIONS AND BALANCES One of the Company’s employees is related to a member of the Company’s executive management team and received approximately $ 103 and $ 85 in salary and benefits during the nine months ended September 30, 2023 and 2022 , respectively.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	8. INCOME TAXES The Company has recorded a recovery of (provision for) income taxes of $ 1,664 and ($ 269 ) for the three and nine months ended September 30, 2023, respectively, compared with a recovery of income taxes of $ 3,183 and $ 14,563 for the same periods last year. 31,655 as of September 30, 2023 and $ 30,419 as of December 31, 2022. The Company cannot presently estimate what, if any, changes to the valuation of its deferred tax assets may be deemed appropriate in the future. If the Company incurs future losses, it may be necessary to record additional valuation allowance related to the deferred tax assets recognized as of September 30, 2023. $ 4,201 and were primarily derived from net operating loss carryforwards.

Segment and Geographic Informat

Segment and Geographic Information	9 Months Ended
	Sep. 30, 2023
Segment Reporting [Abstract]
Segment and Geographic Information	9. SEGMENT AND GEOGRAPHIC INFORMATION Segment reporting is prepared on the same basis that the Company’s Chief Executive Officer, who is the Company’s Chief Operating Decision Maker, manages the business, makes operating decisions and assesses performance. As of September 30, 2023 , the Company’s four segments are as follows: Segment Description Produce The Produce segment produces, markets, and sells premium quality tomatoes, bell peppers and cucumbers. Cannabis – Canada The Cannabis – Canada segment produces and supplies cannabis products to be sold to other licensed providers and provincial governments across Canada and internationally. Cannabis – United States The Cannabis – United States segment develops and sells high-quality, CBD-based health and wellness products including ingestible, edible and topical applications. Energy The Energy business produces power that it sells per a long-term contract to its one customer. The Company’s primary operations are in the United States and Canada. Segment information is summarized below: Three months ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Sales Produce $ 35,712 $ 35,527 $ 114,125 $ 124,052 Cannabis - Canada 28,810 30,394 81,987 81,956 Cannabis - United States 4,988 5,135 15,266 17,971 Energy — — — 136 $ 69,510 $ 71,056 $ 211,378 $ 224,115 Gross margin Produce $ 1,492 $ ( 3,303 ) $ ( 654 ) $ ( 16,560 ) Cannabis - Canada 9,944 8,198 29,114 29,216 Cannabis - United States 3,185 3,523 9,981 12,072 Energy — ( 44 ) ( 21 ) ( 127 ) $ 14,621 $ 8,374 $ 38,420 $ 24,601

Loss Per Share

Loss Per Share	9 Months Ended
	Sep. 30, 2023
Earnings Per Share [Abstract]
Loss Per Share	10. LOSS PER SHARE Basic and diluted net loss per common share is calculated as follows: Three months ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Numerator: Net loss attributable to Village Farms International, Inc. shareholders $ ( 1,299 ) $ ( 8,745 ) $ ( 9,315 ) $ ( 51,817 ) Denominator: Weighted average number of common shares - basic 110,239 88,684 108,214 88,543 Effect of dilutive securities- share-based employee options and awards — — — — Weighted average number of common shares - diluted 110,239 88,684 108,214 88,543 Antidilutive options and awards 6,509 3,627 6,509 3,592 Net loss per ordinary share: Basic $ ( 0.01 ) $ ( 0.10 ) $ ( 0.09 ) $ ( 0.59 ) Diluted $ ( 0.01 ) $ ( 0.10 ) $ ( 0.09 ) $ ( 0.59 )

Shareholders' Equity and Share

Shareholders' Equity and Share Based Compensation	9 Months Ended
	Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]
Shareholders' Equity and Share Based Compensation	11. SHAREHOLDERS’ EQUITY AND SHARE-BASED COMPENSATION Share-based compensation expense for the three and nine months ended September 30, 2023 was $ 747 and $ 3,135 , respectively, and $ 926 and $ 3,004 for the three and nine months ended September 30, 2022, respectively. Stock option activity for the nine months ended September 30, 2023 was as follows: Number of Weighted Weighted Aggregate Outstanding at January 1, 2023 4,089,418 $ 5.76 6.77 $ 152 Granted 2,671,896 $ 0.99 9.17 $ 125 Exercised ( 100,000 ) $ 0.83 $ 71 Forfeited ( 152,500 ) $ 5.15 Outstanding at September 30, 2023 6,508,814 $ 3.84 7.31 $ 99 Exercisable at September 30, 2023 3,147,929 $ 6.11 5.49 $ 2 Performance-based shares activity for the nine months ended September 30, 2023 was as follows: Number of Weighted Average Grant Date Fair Value Outstanding at January 1, 2023 30,000 $ 8.31 Outstanding at September 30, 2023 20,000 $ 8.31 Exercisable at September 30, 2023 20,000 $ 8.31 On January 30, 2023, the Company closed a public offering (the "Offering") of 18,350,000 Common Shares at a price of US$ 1.35 per share together with accompanying warrants to purchase up to 18,350,000 Common Shares, which have an exercise price of US$ 1.65 per share (the "Warrants"). The gross proceeds from the Offering were approximately US$ 25 million before deducting placement agent fees and other offering expenses payable by the Company. The proceeds from the Offering are being used for general working capital. The accompanying Warrants have an exercise price of US$ 1.65 and became exercisable beginning six months from issuance and will expire five years from the date of initial exercisability.

Changes in Non-Cash Working Cap

Changes in Non-Cash Working Capital Items	9 Months Ended
	Sep. 30, 2023
Disclosure Of Changes In Non Cash Working Capital Items [Abstract]
Changes in Non Cash Working Capital Items	12. CHANGES IN NON-CASH WORKING CAPITAL ITEMS Nine Months Ended September 30, 2023 2022 Trade receivables $ ( 475 ) $ ( 1,622 ) Inventories ( 5,284 ) ( 8,873 ) Other receivables 9 ( 12 ) Prepaid expenses and deposits ( 845 ) ( 1,602 ) Trade payables ( 3,624 ) 9,135 Accrued liabilities 5,383 10,219 Lease liabilities ( 1,574 ) — Other assets, net of other liabilities 4,959 4,376 $ ( 1,451 ) $ 11,621

Business, Basis Of Presentati_2

Business, Basis Of Presentation And Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and with the instructions for Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and footnote disclosures normally included in the annual audited consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. The accompanying condensed consolidated statement of financial position as of December 31, 2022 is derived from the Company’s audited financial statements as of that date. Because certain information and footnote disclosures have been condensed or omitted, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto as of and for the year ended December 31, 2022 contained in the Company’s 2022 Annual Report on Form 10-K. In management’s opinion, all normal and recurring adjustments considered necessary for a fair presentation of the financial position, results of operations, and cash flows for the periods presented have been included. When necessary, certain prior year amounts have been reclassified to conform with the current period presentation. For the three and nine months ended September 30, 2022 , share-based compensation has been reclassified to selling, general and administrative expenses on the condensed consolidated Statements of Operations and Comprehensive Income (Loss) to conform with the current period presentation. Interim period operating results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year. The Company believes that the disclosures made in these consolidated financial statements are adequate to make the information not misleading.
Principals of Consolidation	Principals of Consolidation The accompanying condensed consolidated financial statements include Village Farms International, Inc. and its subsidiaries and include the accounts of all majority-owned subsidiaries over which the Company exercises control and, when applicable, entities in which the Company has a controlling financial interest. All significant intercompany balances and transactions have been eliminated in consolidation. Other parties’ interests in entities that the Company consolidates are reported as non-controlling interests within equity, except for mandatorily redeemable non-controlling interests, which are recorded within mezzanine equity. Net income or loss attributable to non-controlling interests is reported as a separate line item below net income or loss. The Company applies the equity method of accounting for its investments in entities for which it does not have a controlling financial interest, but over which it has the ability to exert significant influence. For equity investees in which the Company has an undivided interest in the assets, liabilities and profits or losses of an unconsolidated entity, but does not exercise control over the entity, the Company consolidates its proportional interest in the accounts of the entity.
Translations of Foreign Currencies	Translations of Foreign Currencies The assets and liabilities of foreign subsidiaries with a functional currency other than the U.S. dollar are translated into U.S. dollars at period-end exchange rates, with resulting translation gains or losses included within other comprehensive income or loss. Revenue and expenses are translated into U.S. dollars at average rates of exchange during the applicable period. Substantially all the Company’s foreign operations use their local currency as their functional currency. For foreign operations for which the local currency is not the functional currency, the operation’s non-monetary assets are remeasured into U.S. dollars at historical exchange rates. All other accounts are remeasured at current exchange rates.
General Economic, Regulatory and Market Conditions	General Economic, Regulatory and Market Conditions The Company has experienced, and may continue to experience, direct and indirect negative effects on its business and operations from negative economic, regulatory and market conditions, including recent inflationary effects on fuel prices, labor and materials costs, rising interest rates, potential recessionary impacts and supply chain disruptions that could negatively affect demand for new projects and/or delay existing project timing or cause increased project costs. The extent to which general economic, regulatory and market conditions could affect the Company’s business, operations and financial results is uncertain as it will depend upon numerous evolving factors that management may not be able to accurately predict, and, therefore, any future impacts on the Company’s business, financial condition and/or results of operations cannot be quantified or predicted with specificity.
Recent Accounting Pronouncements	Recent Accounting Pronouncements No accounting pronouncements recently issued or newly effective have had, or are expected to have, a material impact on the Company’s condensed consolidated financial statements.

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 30, 2023
Inventory Disclosure [Abstract]
Schedule of Inventory, Current	Inventories consisted of the following as of: Classification September 30, 2023 December 31, 2022 Cannabis: Raw materials $ 1,180 $ 1,089 Work-in-progress 6,452 10,872 Finished goods 47,510 36,094 Packaging 7,149 6,909 Produce and Energy: Crop inventory 14,028 14,886 Purchased produce inventory 683 599 Spare parts inventory and packaging 57 133 Inventory $ 77,059 $ 70,582

Property Plant And Equipment (T

Property Plant And Equipment (Tables)	9 Months Ended
	Sep. 30, 2023
Property, Plant and Equipment [Abstract]
Summary of Property, Plant and Equipment	Property, plant and equipment consisted of the following as of: Classification September 30, 2023 December 31, 2022 Land $ 13,387 $ 13,411 Leasehold and land improvements 5,533 5,372 Buildings 214,014 214,146 Machinery and equipment 85,494 82,396 Construction in progress 11,786 10,033 Less: Accumulated depreciation ( 128,016 ) ( 117,657 ) Property, plant and equipment, net $ 202,198 $ 207,701

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Changes in Carrying Value of Goodwill by Reportable Segment	The following table presents the changes in the carrying value of goodwill by reportable segment for the nine months ended September 30, 2023: Cannabis - Canada Cannabis - United States Total Balance as of December 31, 2022 $ 44,886 $ 21,339 $ 66,225 Foreign currency translation adjustment ( 107 ) — ( 107 ) Balance as of September 30, 2023 $ 44,779 $ 21,339 $ 66,118
Schedule of Acquired Intangible Assets	Intangibles consisted of the following as of: Classification September 30, 2023 December 31, 2022 Licenses $ 17,983 $ 17,691 Brand and trademarks* 12,710 12,719 Customer relationships 13,260 13,291 Computer software 1,952 1,955 Other* 144 144 Less: Accumulated amortization ( 6,464 ) ( 4,013 ) Less: Impairments ( 4,630 ) ( 4,630 ) Intangibles, net $ 34,955 $ 37,157 * Indefinite-lived intangible assets
Schedule of Expected Future Amortization Expense for Definite-Lived Intangible Assets	The expected future amortization expense for definite-lived intangible assets as of September 30, 2023 was as follows: Fiscal period Remainder of 2023 $ 777 2024 3,107 2025 3,021 2026 2,932 2027 2,932 Thereafter 13,962 Intangibles, net $ 26,731

Line of Credit and Long-term _2

Line of Credit and Long-term Debt (Tables)	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Schedule of Carrying Values of Debt	The following table provides details for the carrying values of debt as of: September 30, 2023 December 31, 2022 Term Loan - ("FCC Loan") - repayable by monthly principal payments of $ 164 and accrued interest at a rate of 8.93 %; matures April 1, 2025 $ 23,280 $ 24,755 Term Loan - Pure Sunfarms - C$ 19.0 M - Canadian prime interest rate plus an applicable margin, repayable in quarterly payments equal to 2.50 % of the outstanding principal amount, interest rate of 9.20 %; matures February, 2026 8,534 9,664 Term loan - Pure Sunfarms - C$ 25.0 M - Canadian prime interest rate plus an applicable margin, repayable in quarterly payments equal to 2.50 % of the outstanding principal amount starting June 30, 2021 , interest rate of 9.20 %; matures February, 2026 13,449 14,867 BDC Facility - Pure Sunfarms - non-revolving demand loan repayable by monthly principal payments of C$ 52 and accrued interest at a rate of 10.95 %, matures December 31, 2031 3,832 4,181 Total $ 49,095 $ 53,467
Schedule of principal maturities of long term debt	The aggregate annual principal maturities of long-term debt for the remainder of 2023 and thereafter are as follows: Remainder of 2023 $ 1,660 2024 5,814 2025 24,668 2026 14,652 2027 460 Thereafter 1,841 Total $ 49,095

Segment and Geographic Inform_2

Segment and Geographic Information (Tables)	9 Months Ended
	Sep. 30, 2023
Segment Reporting [Abstract]
Summary of Net Sales by the Countries and Business	The Company’s primary operations are in the United States and Canada. Segment information is summarized below: Three months ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Sales Produce $ 35,712 $ 35,527 $ 114,125 $ 124,052 Cannabis - Canada 28,810 30,394 81,987 81,956 Cannabis - United States 4,988 5,135 15,266 17,971 Energy — — — 136 $ 69,510 $ 71,056 $ 211,378 $ 224,115 Gross margin Produce $ 1,492 $ ( 3,303 ) $ ( 654 ) $ ( 16,560 ) Cannabis - Canada 9,944 8,198 29,114 29,216 Cannabis - United States 3,185 3,523 9,981 12,072 Energy — ( 44 ) ( 21 ) ( 127 ) $ 14,621 $ 8,374 $ 38,420 $ 24,601

Loss Per Share (Tables)

Loss Per Share (Tables)	9 Months Ended
	Sep. 30, 2023
Income Per Share [Abstract]
Summary of Basic and Diluted Net Loss per Common Share	Basic and diluted net loss per common share is calculated as follows: Three months ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Numerator: Net loss attributable to Village Farms International, Inc. shareholders $ ( 1,299 ) $ ( 8,745 ) $ ( 9,315 ) $ ( 51,817 ) Denominator: Weighted average number of common shares - basic 110,239 88,684 108,214 88,543 Effect of dilutive securities- share-based employee options and awards — — — — Weighted average number of common shares - diluted 110,239 88,684 108,214 88,543 Antidilutive options and awards 6,509 3,627 6,509 3,592 Net loss per ordinary share: Basic $ ( 0.01 ) $ ( 0.10 ) $ ( 0.09 ) $ ( 0.59 ) Diluted $ ( 0.01 ) $ ( 0.10 ) $ ( 0.09 ) $ ( 0.59 )

Shareholders' Equity and Shar_2

Shareholders' Equity and Share Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]
Summary of fair value of stock option valuation assumptions	Stock option activity for the nine months ended September 30, 2023 was as follows: Number of Weighted Weighted Aggregate Outstanding at January 1, 2023 4,089,418 $ 5.76 6.77 $ 152 Granted 2,671,896 $ 0.99 9.17 $ 125 Exercised ( 100,000 ) $ 0.83 $ 71 Forfeited ( 152,500 ) $ 5.15 Outstanding at September 30, 2023 6,508,814 $ 3.84 7.31 $ 99 Exercisable at September 30, 2023 3,147,929 $ 6.11 5.49 $ 2
Summary of non-vested performance-based restricted share units	Performance-based shares activity for the nine months ended September 30, 2023 was as follows: Number of Weighted Average Grant Date Fair Value Outstanding at January 1, 2023 30,000 $ 8.31 Outstanding at September 30, 2023 20,000 $ 8.31 Exercisable at September 30, 2023 20,000 $ 8.31

Changes in Non-Cash Working C_2

Changes in Non-Cash Working Capital Items (Tables)	9 Months Ended
	Sep. 30, 2023
Disclosure Of Changes In Non Cash Working Capital Items [Abstract]
Summary of Changes in Non Cash Working Capital Items	Nine Months Ended September 30, 2023 2022 Trade receivables $ ( 475 ) $ ( 1,622 ) Inventories ( 5,284 ) ( 8,873 ) Other receivables 9 ( 12 ) Prepaid expenses and deposits ( 845 ) ( 1,602 ) Trade payables ( 3,624 ) 9,135 Accrued liabilities 5,383 10,219 Lease liabilities ( 1,574 ) — Other assets, net of other liabilities 4,959 4,376 $ ( 1,451 ) $ 11,621

Business, Basis Of Presentati_3

Business, Basis Of Presentation And Significant Accounting Policies - Additional Information (Detail)	Sep. 30, 2023
Rose LifeScience Inc. [Member]
Nature Of Operations [Line Items]
Equity ownership percentage	70%
Leli Holland B.V. [Member]
Nature Of Operations [Line Items]
Equity ownership percentage	85%

Inventories - Summary of Invent

Inventories - Summary of Inventory Current (Detail) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Inventory [Line Items]
Inventories	$ 77,059	$ 70,582
Raw Materials [Member] | Cannabis Business [Member]
Inventory [Line Items]
Inventories	1,180	1,089
Work-In-Progress [Member] | Cannabis Business [Member]
Inventory [Line Items]
Inventories	6,452	10,872
Finished Goods [Member] | Cannabis Business [Member]
Inventory [Line Items]
Inventories	47,510	36,094
Packaging [Member] | Cannabis Business [Member]
Inventory [Line Items]
Inventories	7,149	6,909
Crop Inventory [Member] | Produce And Energy
Inventory [Line Items]
Inventories	14,028	14,886
Purchased Produce Inventory [Member] | Produce And Energy
Inventory [Line Items]
Inventories	683	599
Spare Parts Inventory and Packinng [Member] | Produce And Energy
Inventory [Line Items]
Inventories	$ 57	$ 133

Property Plant And Equipment -

Property Plant And Equipment - Summary of Property, Plant and Equipment (Detail) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Property Plant And Equipment [Line Items]
Less: Accumulated depreciation	$ (128,016)	$ (117,657)
Property, plant and equipment, net	202,198	207,701
Land [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	13,387	13,411
Leaseholds and Leasehold Improvements [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	5,533	5,372
Buildings [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	214,014	214,146
Machinery and Equipment [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	85,494	82,396
Construction in Progress [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 11,786	$ 10,033

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Schedule of Changes in Carrying Value of Goodwill by Reportable Segment (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2023 USD ($)
Goodwill [Line Items]
Beginning Balance	$ 66,225
Foreign currency translation adjustment	(107)
Ending Balance	66,118
Cannabis Business [Member] | Canada [Member]
Goodwill [Line Items]
Beginning Balance	44,886
Foreign currency translation adjustment	(107)
Ending Balance	44,779
Cannabis Business [Member] | United States [Member]
Goodwill [Line Items]
Beginning Balance	21,339
Ending Balance	$ 21,339

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Schedule of Acquired Intangible Assets (Detail) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Finite Lived Intangible Assets [Line Items]
Less: Accumulated amortization	$ (6,464)	$ (4,013)
Less: Impairments	(4,630)	(4,630)
Intangibles, net	34,955	37,157
Licenses [Member]
Finite Lived Intangible Assets [Line Items]
Intangibles, gross	17,983	17,691
Brand and Trademarks [Member]
Finite Lived Intangible Assets [Line Items]
Intangibles, gross	12,710	12,719
Customer Relationships [Member]
Finite Lived Intangible Assets [Line Items]
Intangibles, gross	13,260	13,291
Computer Software [Member]
Finite Lived Intangible Assets [Line Items]
Intangibles, gross	1,952	1,955
Other [Member]
Finite Lived Intangible Assets [Line Items]
Intangibles, gross	$ 144	$ 144

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Schedule of Expected Future Amortization Expense for Definite-Lived Intangible Assets (Detail) $ in Thousands	Sep. 30, 2023 USD ($)
Fiscal period
Remainder of 2023	$ 777
2024	3,107
2025	3,021
2026	2,932
2027	2,932
Thereafter	13,962
Intangibles, net	$ 26,731

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Additional Information (Detail) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Sep. 30, 2023	Dec. 31, 2022
Goodwill [Line Items]
Goodwill		$ 66,118	$ 66,225
Intangible assets		$ 4,630	$ 4,630
Cannabis U.S. [Member]
Goodwill [Line Items]
Threshold Percentage of Revenue	1.60%
Recovered amount higher (lower) than carrying amount of goodwill	$ (25,169)
Decrease in threshold percentage of revenue	0.25%
Increase in impairment to goodwill	$ 7,000
Recovered amount higher (lower) than carrying amount of brand	9,250
Intangible assets	4,630
Cannabis U.S. [Member] | Increase of 1% to Discount Rate [Member]
Goodwill [Line Items]
Increase in impairment to goodwill	$ 530
Post-tax discount rate	11%
Increase in post-tax discount rate	1%
Cannabis U.S. [Member] | Decrease to Incremental Royalty Rate By 0.50% [Member]
Goodwill [Line Items]
Intangible assets	$ 1,490
Incremental royalty rate	4%
Decrease to incremental royalty rate	0.50%
Cannabis U.S. [Member] | Decrease in Future Revenue Rate by 10% [Member]
Goodwill [Line Items]
Intangible assets	$ 470
Decrease to future revenues rate	10%

Line of Credit and Long-term _3

Line of Credit and Long-term Debt - Schedule of Debt (Detail) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Term Loan	$ 49,095	$ 53,467
Term Loan (FCC Loan) [Member]
Debt Instrument [Line Items]
Term Loan	23,280	24,755
Term Loan One [Member] | Pure Sunfarms [Member]
Debt Instrument [Line Items]
Term Loan	8,534	9,664
Term Loan Two [Member] | Pure Sunfarms [Member]
Debt Instrument [Line Items]
Term Loan	13,449	14,867
BDC Facility [Member] | Pure Sunfarms [Member]
Debt Instrument [Line Items]
Term Loan	$ 3,832	$ 4,181

Line of Credit and Long-term _4

Line of Credit and Long-term Debt - Schedule of Debt (Parenthetical) (Detail) - 9 months ended Sep. 30, 2023 $ in Millions, $ in Millions	USD ($)	CAD ($)
Term Loan (FCC Loan) [Member]
Debt Instrument [Line Items]
Debt instrument, periodic principal payment	$ 164
Debt instrument, interest rate during period	8.93%	8.93%
Debt instrument maturity date	Apr. 01, 2025	Apr. 01, 2025
Term Loan One [Member] | Pure Sunfarms [Member]
Debt Instrument [Line Items]
Debt instrument, periodic principal payment		$ 19
Debt instrument, interest rate during period	9.20%	9.20%
Debt instrument maturity date	Feb. 28, 2026	Feb. 28, 2026
Debt Instrument Quarterly Payments Interest Rate	2.50%	2.50%
Term Loan Two [Member] | Pure Sunfarms [Member]
Debt Instrument [Line Items]
Debt instrument, periodic principal payment		$ 25
Debt instrument, interest rate during period	9.20%	9.20%
Debt instrument maturity date	Feb. 28, 2026	Feb. 28, 2026
Debt Instrument Quarterly Payments Interest Rate	2.50%	2.50%
Debt instrument maturity date	Jun. 30, 2021	Jun. 30, 2021
BDC Facility [Member] | Pure Sunfarms [Member]
Debt Instrument [Line Items]
Debt instrument, periodic principal payment		$ 52
Debt instrument, interest rate during period	10.95%	10.95%
Debt instrument maturity date	Dec. 31, 2031	Dec. 31, 2031

Line of Credit and Long-term _5

Line of Credit and Long-term Debt - Additional Information (Detail) $ in Thousands, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2022 CAD ($)
Disclosure Of Borrowings [Line Items]
Line of credit	$ 4,000	$ 7,529
Weighted average interest rate	9.86%	9.12%	9.12%
Accounts Payable and Accrued Liabilities [Member]
Disclosure Of Borrowings [Line Items]
Accrued interest payable	$ 385	$ 398
Non-Revolving Variable Rate Term Loan 2021 [Member] | FCC Loan [Member]
Disclosure Of Borrowings [Line Items]
Securities pledged as collateral	122,823	113,159
Revolving Operating Loan [Member]
Disclosure Of Borrowings [Line Items]
Amounts drawn on facility	4,000	4,000
Securities pledged as collateral	25,553	26,666
Revolving Operating Loan [Member] | Pure Sunfarms [Member]
Disclosure Of Borrowings [Line Items]
Total outstanding amount	0	$ 3,529
Letter of Credit | Pure Sunfarms [Member]
Disclosure Of Borrowings [Line Items]
Line of credit	$ 0		$ 4,145

Line of Credit and Long-term _6

Line of Credit and Long-term Debt - Summary of Aggregate Annual Principal Maturities of Long-Term Debt (Detail) $ in Thousands	Sep. 30, 2023 USD ($)
Debt Disclosure [Abstract]
Remainder of 2023	$ 1,660
2024	5,814
2025	24,668
2026	14,652
2027	460
Thereafter	1,841
Long-term debt	$ 49,095

Related Party Transactions An_2

Related Party Transactions And Balances - Additional Information (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Employees
Related Party Transaction [Line Items]
Salary and benefits to employee	$ 103	$ 85

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Recovery of (provision for) income taxes	$ 1,664	$ 3,183	$ (269)	$ 14,563
Valuation allowance	31,655		31,655		$ 30,419
Total deferred tax assets	$ 4,201		$ 4,201

Segment and Geographic Inform_3

Segment and Geographic Information - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2023 Segment
Segment Reporting [Abstract]
Number of operating segments	4

Segment and Geographic Inform_4

Segment and Geographic Information - Summary of net sales by the countries and business (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Sales [Abstract]
Sales	$ 69,510	$ 71,056	$ 211,378	$ 224,115
Gross margin [Abstract]
Gross Margin	14,621	8,374	38,420	24,601
Produce Business [Member]
Sales [Abstract]
Sales	35,712	35,527	114,125	124,052
Gross margin [Abstract]
Gross Margin	1,492	(3,303)	(654)	(16,560)
Cannabis Canada Business [Member]
Sales [Abstract]
Sales	28,810	30,394	81,987	81,956
Gross margin [Abstract]
Gross Margin	9,944	8,198	29,114	29,216
Cannabis United States Business [Member]
Sales [Abstract]
Sales	4,988	5,135	15,266	17,971
Gross margin [Abstract]
Gross Margin	$ 3,185	3,523	9,981	12,072
Energy Business [Member]
Sales [Abstract]
Sales				136
Gross margin [Abstract]
Gross Margin		$ (44)	$ (21)	$ (127)

Loss Per Share - Summary of Bas

Loss Per Share - Summary of Basic and Diluted Net Loss per Common Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Numerator:
Net loss attributable to Village Farms International, Inc. shareholders	$ (1,299)	$ (8,745)	$ (9,315)	$ (51,817)
Denominator:
Weighted average number of common shares - basic	110,239	88,684	108,214	88,543
Weighted average number of common shares - diluted	110,239	88,684	108,214	88,543
Antidilutive options and awards	6,509	3,627	6,509	3,592
Net loss per ordinary share:
Basic	$ (0.01)	$ (0.1)	$ (0.09)	$ (0.59)
Diluted	$ (0.01)	$ (0.1)	$ (0.09)	$ (0.59)

Shareholders' Equity and Shar_3

Shareholders' Equity and Share Based Compensation - Additional Information (Detail) - USD ($)		3 Months Ended		9 Months Ended
	Jan. 30, 2023	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share based compensation expense		$ 747,000	$ 926,000	$ 3,135,000	$ 3,004,000
Shares issued in pubic offering, net of issuance costs (in shares)	18,350,000
Purchase price	$ 1.35
Exercise price of warrants	$ 1.65
Proceeds from issuance of common stock after deducting commissions and offering expenses	$ 25
Warrants exercisable beginning year	6 months
Warrants exercisable expiration year	5 years
Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Class of Warrant or Right, Outstanding	18,350,000

Shareholders' Equity and Shar_4

Shareholders' Equity and Share Based Compensation - Summary of Stock Option (Detail) - Stock Option [Member] - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of Options, Beginning balance	4,089,418
Number of Options, Granted	2,671,896
Number of Options, Exercised	(100,000)
Number of Options, Fortified	(152,500)
Number of Options, Ending balance	6,508,814	4,089,418
Number of Options, Exercisable	3,147,929
Weighted Average Exercise Price, Beginning balance	$ 5.76
Weighted Average Exercise Price, Granted	0.99
Weighted Average Exercise Price, Exercised	0.83
Weighted Average Exercise Price,Fortified	5.15
Weighted Average Exercise Price, Ending balance	3.84	$ 5.76
Weighted Average Exercise Price, Exercisable	$ 6.11
Weighted Average Remaining Contractual Term (years)	7 years 3 months 21 days	6 years 9 months 7 days
Weighted Average Remaining Contractual Term (years), Granted	9 years 2 months 1 day
Weighted Average Remaining Contractual Term (years), Exercisable	5 years 5 months 26 days
Aggregate Intrinsic Value	$ 99	$ 152
Aggregate Intrinsic Value, Granted	125
Aggregate Intrinsic Value, Exercised	71
Aggregate Intrinsic Value, Excercisable	$ 2

Shareholders' Equity and Shar_5

Shareholders' Equity and Share Based Compensation - Summary of Performance base restricted share unit activity (Detail) - Performance-Based Restricted Share Unit [Member]	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Number of Performance-based Restricted Share Units, Beginning balance | shares	30,000
Number of Performance-based Restricted Share Units, Ending balance | shares	20,000
Number of Performance-based Restricted Share Units, Exercisable | shares	20,000
Weighted Average Grant Date Fair Value, Beginning balance | $ / shares	$ 8.31
Weighted Average Grant Date Fair Value, Ending balance | $ / shares	8.31
Weighted Average Grant Date Fair Value, Exercisable | $ / shares	$ 8.31

Changes in Non Cash Working Cap

Changes in Non Cash Working Capital Items - Summary of Changes in Non Cash Working Capital Items (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Trade receivables	$ (475)	$ (1,622)
Inventories	(5,284)	(8,873)
Other receivables	9	(12)
Prepaid expenses and deposits	(845)	(1,602)
Trade payables	(3,624)	9,135
Accrued liabilities	5,383	10,219
Lease liabilities	(1,574)
Other assets, net of other liabilities	4,959	4,376
Total	$ (1,451)	$ 11,621